Table 3.
DDDs, DIDs and percentages of DDD of antibiotics according to infection
| Infection | Antimicrobial agents | % children | % adults | DDD children (%) | DDD adults (%) | DID children | DID adults |
|---|---|---|---|---|---|---|---|
| Respiratory | Penicillins J01C | 37.5% | 22% | 344 (48.9%) | 337.5 (33%) | 9.53 | 9.67 |
| Cephalosporins J01DA | 29.2% | 30% | 142 (20.1%) | 306 (30%) | 3.92 | 5.27 | |
| Macrolides, lincozamides J01F | 31.9% | 48% | 204 (29%) | 378 (37%) | 5.65 | 6.51 | |
| Sulphonamides J01E | 1.4% | 0 | 14.4 (2%) | 0 | 0.4 | 0 | |
| Urinary | Penicillins J01C | 8.3% | 24 (18%) | 0.41 | |||
| Cephalosporins J01DA | 25% | 24 (18%) | 0.41 | ||||
| Quinolones J01M | 41.7% | 55 (41.4%) | 0.95 | ||||
| Sulphonamides J01 | 25% | 30 (22.6%) | 0.52 | ||||
| Skin-soft tissues | Penicillins J01C | 42.8% | 6.3% | 15.4 (52.4%) | 12 (8.3%) | 0.58 | 0.21 |
| Cephalosporins J01DA | 28.6% | 62.5% | 6.5 (19.5%) | 88 (60%) | 0.18 | 1.52 | |
| Macrolides, lincozamides J01F | 12.5% | 11 (7.5%) | 0.19 | ||||
| Other | 28.6% | 18.7% | 7.5 (25.5%) | 35.5 (24.2%) | 0.21 | 1.09 | |
| Genital | Other | 100% | 25.5 (100%) | 0.57 | |||
| Gastrointestinal | Macrolides, lincozamides J01F | 50% | 12 (66.7%) | 0.33 | |||
| Other | 50% | 6 (33.3%) | 0.17 | ||||
| Tooth abscess | Penicillins J01C | 80% | 75% | 30 (83.3%) | 72 (90%) | 0.83 | 1.86 |
| Cephalosporins J01DA | 20% | 6 (16.7%) | 0.17 | ||||
| Macrolides, lincozamides J01F | 25% | 8.0 (10%) | 0.14 | ||||
| Various | Other | 100% | 2.5 (100%) | 0.07 |